Comparative biotransformation studies of MeIQx and PhIP in animal models and humans

Cancer Letters

Volumn 143, Issue 2, 1999, Pages 161-165

  Garner, R C ^a   Lightfoot, T J ^a   Cupid, B C ^a   Russell, D ^a   Coxhead, J M ^a   Kutschera, W ^b   Priller, A ^b   Rom, W ^b   Steier, P ^b   Alexander, D J ^c   Leveson, S H ^c   Dingley, K H ^d   Mauthe, R J ^d   Turteltaub, K W ^d  

^a UNIVERSITY OF YORK   (United Kingdom)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c YORK HOSPITAL   (United Kingdom)

^d LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

Author keywords

Accelerator mass spectrometry; Colorectal cancer; DNA adduct; Heterocyclic amine

Indexed keywords

2 AMINO 1 METHYL 6 PHENYLIMIDAZO[4,5 B]PYRIDINE; 2 AMINO 3,8 DIMETHYLIMIDAZO[4,5 F]QUINOXALINE; HETEROCYCLIC AMINE;

ADULT; AGED; ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CARCINOGENESIS; CLINICAL ARTICLE; COLON; COLORECTAL CANCER; CONTROLLED STUDY; DNA ADDUCT; DRUG METABOLISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICOKINETICS; URINARY EXCRETION;

ANIMALS; CARBON RADIOISOTOPES; CARCINOGENS; COLON; DNA ADDUCTS; HUMANS; IMIDAZOLES; QUINOXALINES; RATS; SPECIES SPECIFICITY;

ANIMALIA; RODENTIA;

EID: 0032806626     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(99)00118-4     Document Type: Article

References (21)

1. Doll R., Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States. J. Natl. Cancer Inst. 66:1981;1191-1308.
2. Gerhardsson de Verdier M., Hagman U., Peters R.K., Steineck G., Overik E. Meat, cooking methods and colorectal cancer: a casereferent study in Stockholm. Int. J. Cancer. 49:1991;520-525.
3. Knekt P., Steineck G., Jarvinen R., Hakulinen T., Aromaa A. Intake of fried meat and risk of cancer: a follow up study in Finland. Int. J. Cancer. 59:1994;756-760.
4. Willett W.C., Stampfer M.J., Colditz G.A., Rosner B.A., Spetzer F. Relation of meat and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med. 323:1990;1664-1672.
5. Gross G.A., Turesky R.J., Fay L.B., Stillwell W.G., Skipper P.L., Tannenbaum S.R. Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings. Carcinogenesis. 14:1993;2313-2318.
6. Aoyama T., Gonzalez F.J., Gelboin H.V. Human cDNA-expressed cytochrome P450 1A2: mutagen activation and substrate specificity. Mol. Carcinogen. 2:1989;192-198.
7. Shimada T., Gillam E.M.J., Sandhu P., Guo Z., Tukey R.H., Guengerich F.P. Activation of procarcinogens by human cytochrome P450 enzymes expressed in Escherichia coli. Simplified bacterial systems for genotoxicity assays. Carcinogenesis. 15:1994;2523-2529.
8. Turesky R.J., Lang N.P., Butler M.A., Teitel C.H., Kadlubar F.F. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis. 12:1991;1839-1845.
9. Turesky R.J. Biomonitoring of heterocyclic amines. Crews H.M., Hanley A.B. Biomarkers in Food Chemical Risk Assessment. 1995;56 The Royal Society of Chemistry, Cambridge, UK.
10. Frandsen H., Grivas S., Andersson R., Dragsted L., Larsen J.C. Reaction of the N2-acetoxy derivative of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) with 2′-deoxyguanosine and DNA. Synthesis and identification of N2-(2′-deoxyguanosin-8-yl)-PhIP. Carcinogenesis. 13:1992;629-635.
11. Lin D., Kaderlik K.R., Turesky R.J., Miller D.W., Lay O.J., Kadlubar F.F. Identification of N-[deoxyguanosine-8-yl]-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine with DNA. Chem. Res. Toxicol. 5:1992;691-697.
12. Turesky R.J., Rossi S.C., Welti D.H., Lay O.J. Jr, Kadlubar F.F. Characterisation of DNA adducts formed in vitro by reaction of N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline and N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline at the C-8 and N2 atoms of guanine. Chem. Res. Toxicol. 5:1992;479-490.
13. Ito N., Hasegawa R., Sano M., Tamano S., Esumi H., Takayama S., Sugimura T. new colon and mammary carcinogen in cooked food. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis. 12:1991;1503-1506.
14. Synderwine E.G., Turesky R.J., Turteltaub K.W., Davis C.D., Sadrieh N., Schut H.A.J., Nagao M., Sugimura T., Thorgeirsson U.P., Adamson R.H., Thorgeirsson S.S. Metabolism of food-derived heterocyclic amines in nonhuman primates. Mutat. Res. 376:1997;203-210.
15. Kato T., Ohagaki H., Hasegawa H., Sato S., Takayama S., Sugimura T. Induction of tumours in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a mutagenic compound 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis. 9:1988;71-73.
16. Ohagaki H., Hasegawa H., Suenaga M., Sato S., Takayama S., Sumimura T. Carcinogenicity in mice of a mutagenic compound 2-amino-3,8-dimethylimidazo[4,5-b]quinoxaline. Carcinogenesis. 8:1987;665-668.
17. Vogel J.S., Turteltaub K.W. Accelerator mass spectrometry in biomedical research. Nucl. Inst. Methods Phys. Res. B. 92:1994;445-453.
18. Snyderwine E.G., Buonarati M.H., Felton J.S., Turteltaub K.W. Metabolism of the food-derived mutagen/carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in non-human primates. Carcinogenesis. 14:1993;2517-2522.
19. Turesky R.J., Garner R.C., Welti D.H., Richoz J., Leveson S.H., Dingley K.H., Turteltaub K.W., Fay L.B. Metabolism of the food borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans. Chem. Res. Toxicol. 11:1998;217-225.
20. Dingley K.H., Freeman S.P.H.T., Nelson D.O., Garner R.C., Turteltaub K.W. Covalent Binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and haemoglobin at environmentally-relevant doses: a comparison of humans and the F344 rat. Drug Met. Dispos. 26:1998;825-828.
21. Gaylor D.W., Kadlubar F.F., Beland F.A. Application of biomarkers to risk assessment. Environ. Health. Perspect. 98:1992;139-141.